(14) The term “supplement” means a request to the Secretary to approve a change in a biosimilar biological product application which has been approved, including a supplement requesting that the Secretary determine that the biosimilar biological product meets the standards for interchangeability described in section 262(k)(4) of title 42 .


21 USC § 379j-51(14)

Scoping language

For purposes of this subpart
Is this correct? or